Best Addiction and Substance Abuse Grants in Georgia

Addiction and substance use organizations in Georgia can seek support for prevention, treatment, harm reduction, and recovery programs through the Georgia Opioid Crisis Abatement Trust. Grants from Georgia Opioid Crisis Abatement Trust help Georgia providers expand services, strengthen recovery supports, and invest in research, training, and education to address the opioid epidemic statewide.

Georgia public charities addressing addiction, alcoholism, homelessness, veterans, seniors, or related health and social challenges can access funding through the Scott Hudgens Family Foundation. Eligible 501(c)(3) organizations must primarily serve Gwinnett County, with secondary focus on metro Atlanta and the wider state, and may also propose education, workforce training, arts, or capital projects.

About CommonSpirit

A calling that defines and unites

At CommonSpirit Health, we passionately care for the most vulnerable, relentlessly innovate how and where healing can happen and believe in uniting to benefit the common good. Our expansive network spans diverse communities, uniquely positioning us to meet their changing needs, improve population health and help chart the path to health equity.

Our mission, vision and values inform every aspect of our work each day and remind us that we serve our patients, their families, our communities – and each other. Our community health, research and home health programs help us address the primary barriers to healthier communities.

Sponsorship requests

We’re proud to support nonprofits that expand access to care, advance health equity and healthier communities. Learn more about our priorities.

Supporting our communities

CommonSpirit Health and our local facilities support nonprofit organizations that share our mission, vision and values. We give priority to programs that improve access to care and promote health equity and healthier communities.

CommonSpirit is proud to support nonprofit organizations that help improve the health and well-being of our communities. Guided by our mission, vision and values, we prioritize projects that focus on advancing health equity, improving access to care and improving community wellness.

Georgia 501(c)(3) public charities working on mental health and substance use disorder treatment or prevention can apply for Elevance Health Foundation’s Behavioral Health Grant to support scalable community programs. Funding supports increasing access to MH/SUD treatment, early-intervention strategies, and reducing loneliness, with opportunities for both local Georgia initiatives and national programs including Georgia communities.

Georgia addiction and substance use organizations conducting adult-focused research can access funding through the National Institutes of Health to test SBIRT/P approaches for alcohol, tobacco, and other drug use. Projects must prospectively evaluate screening, brief intervention, and referral to treatment or prevention, and build collaborations with healthcare and community partners; eligible work may also serve broader U.S. populations.

Research institutions and healthcare or community partners in the U.S., including Georgia, can apply for National Institutes of Health funding to test SBIRT/P approaches addressing alcohol, tobacco, and other drug use among adults experiencing health disparities. Grants from NIH help addiction and substance use organizations evaluate screening, brief intervention, and referral-to-treatment or prevention models over multiple application cycles.

Georgia local education agencies in Georgia seeking to reduce student vaping can apply for the Georgia Department of Education’s Student Vaping Mini-Grant, offering up to US $25,000 for school-based interventions. Funding supports coordinated efforts in one feeder middle school and one high school to address addiction and substance use disorders among students.

Nonprofit organizations and local governments working on addiction and substance use disorders, health, housing, public safety, and related services in Georgia may be eligible if they are Native American organizations under this nationwide program. Focused on education, health, and addiction issues, the Confederated Tribes of Siletz Indians supports diverse charitable initiatives through the Siletz Tribal Charitable Contribution Fund.

This NOFO invites applications for innovative research aimed at developing and implementing interventions to prevent and treat substance use disorders (SUDs) and overdose. It encourages studies that can rapidly advance candidate solutions towards regulatory approval or clinical use, while also addressing co-morbid SUDs. The initiative supports a wide range of research including basic, clinical, translational, and implementation strategies to tackle drug misuse and related health issues, such as HIV/AIDS.

Just One More Grant aims to transform lives by providing financial support to individuals and nonprofit organizations in the U.S. who are overcoming challenges like mental health issues, drug misuse, and educational barriers. The foundation encourages applications from those committed to personal growth and community support. Though current grants are paused for nonprofits, interested individuals with actionable plans are invited to apply. More information and past winners can be found on their website.

Research institutions and organizations conducting addiction and substance use disorder studies in Georgia can access funding through the National Institutes of Health to translate epidemiology, prevention, treatment, and recovery research into practice. NIH provides U.S. addiction and substance use disorder researchers with up to US $750,000 to develop scalable, evidence-based approaches that reduce substance use, misuse, and overdose deaths.

The Opioid Crisis Response Program Fellowship, offered by Equal Justice Works, addresses the opioid epidemic by mobilizing public interest lawyers to provide vital civil legal aid to underserved communities affected by Opioid Use Disorder. This two-year fellowship enables attorney fellows to advocate for clients' rights, reduce barriers to treatment, and enhance community education about legal impacts. Through collaboration with various stakeholders, the program aims to improve health outcomes and foster systemic change in the fight against this public health crisis.

The National Cooperative Drug/Device Discovery/Development Groups (NCDDG) program invites applications to foster innovative research in treating mental disorders and substance use issues. This initiative promotes collaboration between academia and industry, supporting diverse, multidisciplinary projects aimed at developing rational therapies and neurostimulation techniques. Applicants are encouraged to submit Letters of Intent 30 days before the proposal deadline to enhance project alignment with funding goals.

The NCDDG program supports innovative research aiming to discover and develop new treatments for mental disorders, including substance use and alcohol use disorders. This initiative encourages collaborations between academic and industry partners to advance neurostimulation techniques and drug/device development. Applicants are invited to submit proposals that focus on specific projects utilizing the U01 mechanism, with a clear emphasis on rationally designed candidate agents and cutting-edge technologies. Letters of Intent are encouraged 30 days prior to the submission deadline.

The Chemical Countermeasures Research Program (CCRP) Initiative aims to support vital research on the harmful effects of acute exposure to Ultra-Potent Synthetic (UPS) opioids, including fentanyl and its combinations. This funding opportunity encourages studies that enhance understanding and mitigation strategies for these substances, focusing on both immediate and long-term health impacts. Applications are due by 5:00 PM local time, with optional Letters of Intent accepted 30 days prior to the proposal deadline.

The NIDA Research Education Program (R25) aims to enhance the training of a workforce skilled in biomedical, behavioral, and clinical research, particularly regarding substance use disorders. This program supports educational activities that prepare clinicians and clinical researchers. Applications are due by 5:00 PM local time, with optional Letters of Intent encouraged 30 days prior to the full proposal deadline. This initiative does not fund non-research-related clinical training.

The Tobacco, Alcohol, and Cannabis Policy Research for Health Equity grant aims to support research on policies affecting tobacco, alcohol, and cannabis use in the U.S. This initiative focuses on how these policies impact populations facing health disparities. Key components include engaging community organizations to advance equity in cancer prevention. Important deadlines for applications range from February 2025 to October 2027, providing opportunities for both standard and renewal submissions.

Research institutions and similar organizations studying tobacco, alcohol, or cannabis policy impacts on substance use and exposure among disparity-affected populations in Georgia can seek funding through the National Institutes of Health. Grants from NIH support U.S.-based policy research with authentic community partnerships to advance health equity and cancer prevention, with awards up to US $275,000.

Research institutions studying addiction and substance use disorders in the U.S., including Georgia, can seek NIH support for time-sensitive pilot or exploratory studies. US Dept. of Health & Human Services: National Institutes of Health offers up to US $275,000 for rapid-response epidemiology and health services research on emerging drug issues, marijuana trends, prescription misuse, healthcare systems, and justice-related drug concerns.

Georgia research institutions and clinical trial teams studying analgesics, anesthetics, addiction medicine, and pain medicine can access funding through the US Department of Health & Human Services: Food and Drug Administration for comprehensive, evidence-based projects. Awards of US $2,000,000 support clinical trials, outcome measures, and systematic reviews to advance safer prescribing and treatment for substance use and pain disorders.

The NIH is offering access to biospecimens from the ABCD, HBCD, and PATH studies to promote research on health and disease across a lifetime. This initiative encourages projects that utilize these samples to deepen understanding of genetic and environmental influences, particularly substance exposure. Researchers can submit proposals to maximize the scientific utility of these resources, in alignment with the goals outlined under federal health regulations.

The National Institute on Drug Abuse (NIDA) is launching a specialized entrepreneurship program aimed at life science researchers in the field of substance use disorders (SUD). This initiative will equip researchers with essential skills to transform their innovative ideas into viable products, focusing on aspects such as market evaluation, customer discovery, and intellectual property. The course will be delivered in a hybrid format to engage US-based SUD researchers effectively, fostering collaboration and advancing the field.

Research institutions and other eligible organizations conducting addiction and HIV-related studies in Georgia and nationwide can seek future NIH funding for pilot and feasibility projects. The U.S. Department of Health and Human Services’ National Institutes of Health supports early-stage work on substance use prevention, treatment, recovery services, and HIV in substance use settings to prepare for larger trials.

The Rural Opioid Technical Assistance Centers program aims to provide essential training and technical assistance to combat opioid and stimulant misuse in rural areas. With 10 Regional Centers and a National Coordinating Office, the initiative focuses on high-quality prevention, treatment, and recovery support services for substance use disorders. This program anticipates awarding 11 new grants to enhance community health and safety in addressing polysubstance use challenges.

The HEAL Initiative aims to combat the opioid crisis through action-oriented research that enhances the translation of addiction epidemiology, prevention, treatment, and recovery services into practice. It prioritizes scalable, evidence-based approaches targeting various levels, including individual and community. The initiative supports a range of methods for research deployment, emphasizing collaboration between researchers and decision-makers to improve outcomes for those affected by addiction and related chronic pain.

The Strengthening Services to Prevent the Infectious Disease Consequences of Drug Use initiative aims to enhance prevention services for infectious diseases among people who use drugs (PWUD). It encompasses two components: a biennial survey to assess service gaps and capacity, and increased support for testing and treatment services. The initiative seeks to improve data utilization in service provision, ultimately increasing testing for HBV, HCV, and HIV, and ensuring more PWUD engage in treatment and care.

The Drug-Free Communities (DFC) Support Program, initiated by the Drug-Free Communities Act of 1997, aims to bolster community coalitions dedicated to preventing youth substance use. Funded by the US HHS's Substance Abuse and Mental Health Services Administration (SAMHSA), this program focuses on collaboration among various stakeholders, including government and non-profit entities, to effectively reduce substance abuse among youth and promote protective factors within communities.